HIV can develop resistance to CRISPR/Cas9

The CRISPR/Cas9 gene-editing platform may need a little bit more tweaking before it can be used as an effective antiviral, reports a study published in Cell Reports.

Be the first to comment

Leave a Reply

Your email address will not be published.


*